Acuta Capital Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-64,627
Closed -$279K 69
2016
Q2
$279K Buy
+64,627
New +$299K 0.13% 53

Other funds holding CDNA

Acuta Capital Partners's CDNA Position: Q3 2016 in Review

Acuta Capital Partners sold out of CareDx (CDNA) in Q3 2016, closing a stake of 64,627 shares — an estimated $279K sold.

Acuta Capital Partners first reported a position in CDNA in Q2 2016 and held it in 1 quarter. The position peaked at $279K in Q2 2016. 25 funds tracked by Wall St. Rank hold CDNA as of Q3 2016.

  • Acuta Capital Partners reported no remaining CareDx position as of Q3 2016 after selling out during the quarter.
  • Acuta Capital Partners sold 64,627 CareDx shares in Q3 2016, an estimated $279K.
  • Acuta Capital Partners first reported a position in CareDx in Q2 2016 and held it in 1 quarter.
  • Acuta Capital Partners's CareDx position peaked at $279K in Q2 2016.
  • 25 funds tracked by Wall St. Rank held CareDx as of Q3 2016.

Based on Acuta Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.